Skip to main content
Clinical Trials/DRKS00010273
DRKS00010273RecruitingNot Applicable

ong Term Surveillance of Patients with Right ventricular outflow tract dysfunction treated by surgical conduit implantation versus percutaneous pulmonary valve implantation with Melody Valve

Deutsches Herzzentrum München0 sites400 target enrollmentStarted: April 14, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
400

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
5 Years to 90 Years (—)
Sex
All

Inclusion Criteria

  • All patients >= 5 years who received either a percutaneous Melody valve
  • or a biological conduit for RVOT dysfunction at the German Heart Centre Munich since 2006
  • -Patient informed consent / data release form

Exclusion Criteria

  • Patients < 5 years of age
  • Previous percutaneous valve implantation
  • No Patient informed consent

Investigators

Sponsor
Deutsches Herzzentrum München

Similar Trials